Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05956340 · ClinicalTrials.gov registry record · NA
A Study of Spoken Language in Mania
A NA study of Bipolar I Disorder and Manic Episode, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT05956340: Completed NA study of Bipolar I Disorder and Manic Episode, sponsored by Mayo Clinic.
NCT05956340 is a NA study of Bipolar I Disorder and Manic Episode that has completed, run by Mayo Clinic. The registered enrollment target is 17 participants, below the 329-participant average among 26 other Bipolar I Disorder trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05956340, a NA study of Bipolar I Disorder and Manic Episode, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
This research is being done to find if there are changes with voice and speech during episodes of mania.
Primary Outcome
The raw audio data will be analyzed for change in pitch, variability of rhythm, and response time.
Conditions Studied
Interventions
- BEHAVIORAL Research interview
Study Locations (1)
Minnesota
- Mayo Clinic Minnesota - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2023-04-27 |
| Est. Completion | 2024-09-09 |
| Phase | NA |
What the finished NCT05956340 record still lists
NCT05956340 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 329-participant average among 26 other Bipolar I Disorder trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Bipolar I Disorder appearing as the primary indexed condition, and to 1 intervention - of which Research interview is the first listed.
NCT05956340 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05956340 about?
NCT05956340 is a clinical study titled "A Study of Spoken Language in Mania". This research is being done to find if there are changes with voice and speech during episodes of mania.
What is the current status of trial NCT05956340?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2023-04-27. Estimated completion is 2024-09-09.
What conditions does trial NCT05956340 study?
This clinical trial studies the following conditions: Bipolar I Disorder, Manic Episode.
What interventions are being tested in trial NCT05956340?
The interventions under investigation include: Research interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT05956340?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05956340 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar I Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05956340's enrollment target sits among peer trials
17 26th of 26 higher than 1 of 26 other Bipolar I Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bipolar I Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder
RECRUITING · NA
-
Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression
ACTIVE NOT RECRUITING · NA
-
LiveWell: A Mobile Intervention for Bipolar Disorder
COMPLETED · NA
-
Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders
RECRUITING · Phase 2
-
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
RECRUITING · Phase 3
-
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI